Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03365882
Title S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Southwest Oncology Group

rectum adenocarcinoma

colon adenocarcinoma


Cetuximab + Irinotecan

Pertuzumab + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST